Aspect-based drug review classification through a hybrid model with ant colony optimization using deep learning

Abstract

The task of aspect-level sentiment analysis is intricately designed to determine the sentiment polarity directed towards a specific target within a sentence. With the increasing availability of online reviews and the growing importance of healthcare decisions, analyzing drug reviews has become a critical task. Traditional sentiment analysis, which categorizes a whole review as positive, negative, or neutral, provides limited insights for consumers and healthcare professionals. Aspect-based sentiment analysis (ABSA) aims to overcome these limitations by identifying and evaluating the sentiment associated with specific aspects or attributes of drugs mentioned in the reviews. Various fields, including business, politics, and medicine, have been explored in the context of sentiment analysis. Automation of online user reviews allows pharmaceutical companies to assess large amounts of user feedback. This helps extract pharmacological efficacy and side effect insights. The data collected could improve pharmacovigilance. Reviewing user comments can provide valuable data that can be used to improve drug safety and efficacy monitoring procedures. This improves pharmacovigilance processes, improving pharmaceutical outcomes understanding and corporate decision-making. Therefore, we propose a pre-trained RoBERTa with a Bi-LSTM model to categorise drug reviews from online sources and pre-process the text data. Ant Colony Optimization can be used in feature selection for ABSA, helping to identify the most relevant aspects and sentiments. Further, RoBERTa is fine-tuned to perform ABSA on the dataset, enabling the system to categorize aspects and determine the associated sentiment. The outcomes reveal that the suggested framework has achieved higher accuracy (96.78%) and F1 score (98.29%) on druglib.com, and 95.02% on the drugs.com dataset, than several prior state-of-the-art methods.